Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination
Siok Shen Ng, Raymond Hutubessy, Nathorn Chaiyakunapruk
Vaccine (2018) Vol. 36, Iss. 19, pp. 2529-2544
Closed Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs
Raúl Murillo, Camila Ordóñez‐Reyes
International Journal of Gynecological Cancer (2019) Vol. 29, Iss. 8, pp. 1317-1326
Closed Access | Times Cited: 18
Penile cancer: a Brazilian consensus statement for low- and middle-income countries
Andrey Soares, Ícaro Thiago de Carvalho, Aluízio Gonçalves da Fonseca, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 12, pp. 3281-3296
Open Access | Times Cited: 15
Long-term effect of mobile phone-based education and influencing factors of willingness to receive HPV vaccination among female freshmen in Shanxi Province, China
Liying Sun, Jingjing Hu, Huihui Gao, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 9
Spatial distribution, determinants and trends of full vaccination coverage in children aged 12–59 months in Peru: A subanalysis of the Peruvian Demographic and Health Survey
Ali Al‐kassab‐Córdova, Claudia Silva-Perez, Jorge L. Maguiña
BMJ Open (2022) Vol. 12, Iss. 11, pp. e050211-e050211
Open Access | Times Cited: 9
Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts
I. Diakité, Bruno Martins, Kwame Owusu‐Edusei, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 5, pp. 965-990
Open Access | Times Cited: 1
Estimating the time required to reach HPV vaccination targets across Europe
Ilias Gountas, Mohammed Aman, D.S. Alexander, et al.
Expert Review of Vaccines (2024)
Open Access | Times Cited: 1
Prevalence and economic burden of male anogenital wart in Korea: A population-based big data analysis from 2007 to 2018
Hong Chung, Jin Bong Choi, Sooyoun Kim, et al.
Investigative and Clinical Urology (2024) Vol. 65, Iss. 6, pp. 579-579
Open Access | Times Cited: 1
Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa
Admire Chikandiwa, Pedro T. Pisa, E Müller, et al.
Sexually Transmitted Diseases (2019) Vol. 46, Iss. 5, pp. 347-353
Open Access | Times Cited: 12
Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis
Cheuk‐Wai Choi, Kathy Leung, Karen K. L. Chan, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium
Steven Simoens, André Bento‐Abreu, Barbara Merckx, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
A Review of Ethical and Legal Aspects of Gender-Neutral Human Papillomavirus Vaccination
Margaret Logel, Cassandra Laurie, Mariam El‐Zein, et al.
Cancer Epidemiology Biomarkers & Prevention (2022) Vol. 31, Iss. 5, pp. 919-931
Open Access | Times Cited: 6
Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan
Cody Palmer, Keisuke Tobe, Yusuke Negishi, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 1546-1554
Open Access | Times Cited: 3
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis
Romina A. Tejada, Talía Malagón, Eduardo L. Franco
Vaccine (2022) Vol. 40, Iss. 19, pp. 2667-2678
Closed Access | Times Cited: 5
Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial
Zhaojun Mo, Zhaofeng Bi, Sheng Wei, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 5
EBCOG position statement: Gender neutral HPV vaccination for young adults
René H.M. Verheijen, Tahir Mahmood, Gilbert Donders, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2020) Vol. 246, pp. 187-189
Closed Access | Times Cited: 7
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
Kwame Owusu‐Edusei, Cody Palmer, Olga Ovcinnikova, et al.
Journal of health economics and outcomes research (2022) Vol. 9, Iss. 1, pp. 140-150
Open Access | Times Cited: 4
Gesundheitsökonomie der Krebsfrüherkennung in Deutschland: Welche Interventionen sind kosteneffektiv bei bevölkerungsweiter Umsetzung?
Michael Schlander, Chih‐Yuan Cheng, Tao Ran
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2018) Vol. 61, Iss. 12, pp. 1559-1568
Closed Access | Times Cited: 4
A human rights approach to understanding provider knowledge and attitudes toward the human papillomavirus vaccine in São Paulo, Brazil
Meredith H. Kruse, Robert A. Bednarczyk, Dabney P. Evans
Papillomavirus Research (2020) Vol. 9, pp. 100197-100197
Open Access | Times Cited: 4
Human Papilloma Virus (HPV) vaccination in Italy: towards new perspectives and new challenges
Vittoria Colamesta, Adriano Grossi, Andréa Barbará, et al.
Epidemiology Biostatistics and Public Health (2022) Vol. 15, Iss. 4
Open Access | Times Cited: 3
An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines
Phuong T. Tran, Munaza Riaz, Ziyan Chen, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 5, pp. 377-390
Closed Access | Times Cited: 3
A survey of healthcare workers’ recommendations about human papillomavirus vaccination
Hitomi Nishioka, Tomoko Onishi, Taito Kitano, et al.
Clinical and Experimental Vaccine Research (2022) Vol. 11, Iss. 2, pp. 149-149
Open Access | Times Cited: 3
Evaluating the cost and operational context for national human papillomavirus (HPV) vaccine delivery in three regions of Ethiopia
Mercy Mvundura, Amare Bayeh, Meseret Zelalem, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 7, pp. e0003357-e0003357
Open Access
Patterns of basic pneumococcal conjugated vaccine coverage in Ethiopia from 2015 to 2018; further analysis of Ethiopian DHS (2016–2019)
Mulugeta Gamachu, Ibsa Mussa, Alemayehu Deressa, et al.
Vaccine X (2024) Vol. 17, pp. 100428-100428
Open Access
Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies
Adikara Pagan Pratama, Su-Feng Chen, Shih‐Chieh Liao, et al.
Journal of Dental Sciences (2024) Vol. 19, Iss. 4, pp. 2045-2056
Open Access


Journal of Gynecology & Reproductive Medicine (2024) Vol. 8, Iss. 2
Open Access

Scroll to top